loading...| Preferred Name |
Dapsone |
|
| Synonyms |
Sulphadione Bis(4-aminophenyl)sulfone Diphenasone 4,4'-Sulfonylbisbenzamine Sulfona-Mae Croysulfone Bis(4-aminophenyl) sulfone 4,4'-Sulfonyldianiline 4,4'-Sulfonylbisbenzeneamine Sulfona-MAE 4,4'-Sulfonylbis[benzenamine] 1358F Aczone Avlosulfon DADPS DAPSONE DDS Dapsone Disulone Dumitone Eporal Novophone Undolac dapsone |
|
| Definitions |
A synthetic derivative of diamino-sulfone with anti-inflammatory and anti-bacterial properties. As a structural analog of p-aminobenzoic acid (PABA), dapsone inhibits dihydropteroate synthase (DHPS), an enzyme important in folate synthesis, resulting in a depletion of the folate pool and a reduction in the amount of thymidylate available for DNA synthesis. Although the exact mechanism through which dapsone exerts its anti-inflammatory activity has yet to be fully elucidated, this agent interferes with the activation and oxidative damage of myeloperoxidase in neutrophils and inhibits the integrin-mediated adherence and chemotaxis of neutrophils. Dapsone's anti-inflammatory activities may contribute to the effects seen upon topical administration. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C415 |
|
| Accepted_Therapeutic_Use_For |
Acne vulgaris; Dermatitis herpetiformis; Leprosy |
|
| ALT_DEFINITION |
A drug used to treat acne. It is also used to treat other types of skin diseases and certain bacterial infections, such as leprosy. It blocks bacteria from making a substance that they need to grow. Dapsone is a type of antibacterial agent and a type of anti-inflammatory agent. |
|
| CAS_Registry |
80-08-0 |
|
| CHEBI_ID |
CHEBI:4325 |
|
| Chemical_Formula |
C12H12N2O2S |
|
| code |
C415 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 |
|
| Contributing_Source |
FDA HemOnc |
|
| DEFINITION |
A synthetic derivative of diamino-sulfone with anti-inflammatory and anti-bacterial properties. As a structural analog of p-aminobenzoic acid (PABA), dapsone inhibits dihydropteroate synthase (DHPS), an enzyme important in folate synthesis, resulting in a depletion of the folate pool and a reduction in the amount of thymidylate available for DNA synthesis. Although the exact mechanism through which dapsone exerts its anti-inflammatory activity has yet to be fully elucidated, this agent interferes with the activation and oxidative damage of myeloperoxidase in neutrophils and inhibits the integrin-mediated adherence and chemotaxis of neutrophils. Dapsone's anti-inflammatory activities may contribute to the effects seen upon topical administration. |
|
| FDA_UNII_Code |
8W5C518302 |
|
| FULL_SYN |
Sulphadione Bis(4-aminophenyl)sulfone Diphenasone 4,4'-Sulfonylbisbenzamine Sulfona-Mae Croysulfone Bis(4-aminophenyl) sulfone 4,4'-Sulfonyldianiline 4,4'-Sulfonylbisbenzeneamine Sulfona-MAE 4,4'-Sulfonylbis[benzenamine] 1358F Aczone Avlosulfon DADPS DAPSONE DDS Dapsone Disulone Dumitone Eporal Novophone Undolac dapsone |
|
| label |
Dapsone |
|
| Legacy Concept Name |
Dapsone |
|
| NCI_Drug_Dictionary_ID |
40323 |
|
| NSC Number |
6091 |
|
| PDQ_Closed_Trial_Search_ID |
40323 |
|
| PDQ_Open_Trial_Search_ID |
40323 |
|
| Preferred_Name |
Dapsone |
|
| prefixIRI |
Thesaurus:C415 |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0010980 |
|
| subClassOf |